10.02.13
Carlsbad, Calif.-based Alphatec Spine Inc., is rolling out several new products at the upcoming North American Spine Society (NASS) annual meeting (Oct. 9-12) in New Orleans, La.
Among the new product introductions is the ILLICO Multi-Level (ML) minimally invasive surgery (MIS) system, used in posterior fixation for addressing instability in the thoracic and lumbar spine. According to the company, ILLICO ML system allows surgeons to address complex multi-level spinal trauma and deformities and ensure "reliable reproducible results," which are designed to minimize pain and help speed patient recovery. This system features the minimally invasive ILLICO MIS Posterior Fixation System and the ILLICO FS Facet Fixation screws.
Also at NASS, Alphatec will unveil its NEXoss Nanostructure BA Matrix, a next-generation synthetic bone graft that company officials claim provides the "optimal microenvironment to support reliable, consistent bone growth for patients during the healing process." Alphatec NEXoss comprises a bioactive scaffold engineered to support successful posterolateral fusions using two patented technologies that work in tandem—a unique collagen biopolymer that contributes to bone growth and nanostructure hydroxyapatite crystals that mimic natural bone composition, structure and size.
The company also will feature its Pegasus Anchored Cervical Interbody System, its newest anchored, cervical interbody device that provides surgeons with a simplified approach to anterior cervical discectomy and fusion procedures. Pegasus provides the delivery of a spacer with an integrated anchoring mechanism in a single-step, non-impaction implantation, which is designed to reduce operative time. The controlled anchor deployment provides surgeons confidence and simple intra-operative and post-operative removal if needed, officials noted.
The fourth technology on Alphatec's agenda during NASS is its Solus Anterior Lumbar Interbody Fusion (ALIF) Device, which is designed to provide improved stabilization for ALIF procedures using a single-step process. Alphatec Solus delivers four points of fixation that are deployed simultaneously while providing substantial space to insert bone graft to help promote rapid fusion at the site, all of which are designed to increase fixation and decrease operative time, according to the company.
"With our focus on physician-inspired solutions we are very excited to be able to join researchers, key thought leaders, and physicians at the 28th annual NASS meeting this month to discuss innovations in the field of spinal disorders and related conditions that can help lead to promising new therapeutic options for patients," said Les Cross, chairman and CEO of Alphatec Spine. "We look forward to demonstrating the unique value and benefits of our broad portfolio of complementary products that help play a role in enabling patients to regain their active lifestyles and live better lives."
In addition, on Thursday, Oct. 10, at 5:30 p.m., Alphatec is hosting an educational symposium featuring Antonio Castellvi, M.D.; Boyle Cheng, Ph.D.; and Celeste Abjornson, Ph.D. They will be speaking about key topics in the prevention and treatment of spinal injuries and related conditions, including minimally invasive techniques for multi-level constructs with ILLICO, results of a biomechanical study of the Novel ALIF device with integrated fixation and next-generation bone grafting solutions. The company also will offer interactive sawbones workshops at its booth during exhibit hours.
Alphatec Spine is a wholly owned subsidiary of Alphatec Holdings Inc.. The company makes devices for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration.
If you're attending NASS, you can visit Alphatec at booth 631.
Among the new product introductions is the ILLICO Multi-Level (ML) minimally invasive surgery (MIS) system, used in posterior fixation for addressing instability in the thoracic and lumbar spine. According to the company, ILLICO ML system allows surgeons to address complex multi-level spinal trauma and deformities and ensure "reliable reproducible results," which are designed to minimize pain and help speed patient recovery. This system features the minimally invasive ILLICO MIS Posterior Fixation System and the ILLICO FS Facet Fixation screws.
Also at NASS, Alphatec will unveil its NEXoss Nanostructure BA Matrix, a next-generation synthetic bone graft that company officials claim provides the "optimal microenvironment to support reliable, consistent bone growth for patients during the healing process." Alphatec NEXoss comprises a bioactive scaffold engineered to support successful posterolateral fusions using two patented technologies that work in tandem—a unique collagen biopolymer that contributes to bone growth and nanostructure hydroxyapatite crystals that mimic natural bone composition, structure and size.
The company also will feature its Pegasus Anchored Cervical Interbody System, its newest anchored, cervical interbody device that provides surgeons with a simplified approach to anterior cervical discectomy and fusion procedures. Pegasus provides the delivery of a spacer with an integrated anchoring mechanism in a single-step, non-impaction implantation, which is designed to reduce operative time. The controlled anchor deployment provides surgeons confidence and simple intra-operative and post-operative removal if needed, officials noted.
The fourth technology on Alphatec's agenda during NASS is its Solus Anterior Lumbar Interbody Fusion (ALIF) Device, which is designed to provide improved stabilization for ALIF procedures using a single-step process. Alphatec Solus delivers four points of fixation that are deployed simultaneously while providing substantial space to insert bone graft to help promote rapid fusion at the site, all of which are designed to increase fixation and decrease operative time, according to the company.
"With our focus on physician-inspired solutions we are very excited to be able to join researchers, key thought leaders, and physicians at the 28th annual NASS meeting this month to discuss innovations in the field of spinal disorders and related conditions that can help lead to promising new therapeutic options for patients," said Les Cross, chairman and CEO of Alphatec Spine. "We look forward to demonstrating the unique value and benefits of our broad portfolio of complementary products that help play a role in enabling patients to regain their active lifestyles and live better lives."
In addition, on Thursday, Oct. 10, at 5:30 p.m., Alphatec is hosting an educational symposium featuring Antonio Castellvi, M.D.; Boyle Cheng, Ph.D.; and Celeste Abjornson, Ph.D. They will be speaking about key topics in the prevention and treatment of spinal injuries and related conditions, including minimally invasive techniques for multi-level constructs with ILLICO, results of a biomechanical study of the Novel ALIF device with integrated fixation and next-generation bone grafting solutions. The company also will offer interactive sawbones workshops at its booth during exhibit hours.
Alphatec Spine is a wholly owned subsidiary of Alphatec Holdings Inc.. The company makes devices for the treatment of spinal disorders associated with trauma, congenital deformities, disease and degeneration.
If you're attending NASS, you can visit Alphatec at booth 631.